These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 15107330)

  • 41. Interobserver reproducibility in reporting on 99mTc-DMSA scintigraphy for detection of late renal sequelae.
    Ladron De Guevara D; Franken P; De Sadeleer C; Ham H; Piepsz A
    J Nucl Med; 2001 Apr; 42(4):564-6. PubMed ID: 11337542
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparison and discrepancy of 18F-2-deoxyglucose positron emission tomography and Tc-99m MDP bone scan to detect bone metastases.
    Kao CH; Hsieh JF; Tsai SC; Ho YJ; Yen RF
    Anticancer Res; 2000; 20(3B):2189-92. PubMed ID: 10928175
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pentavalent rhenium-188 dimercaptosuccinic acid for targeted radiotherapy: synthesis and preliminary animal and human studies.
    Blower PJ; Lam AS; O'Doherty MJ; Kettle AG; Coakley AJ; Knapp FF
    Eur J Nucl Med; 1998 Jun; 25(6):613-21. PubMed ID: 9618576
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pentavalent technetium-99m dimercaptosuccinic acid [99m Tc-(V)DMSA] brain scintitomography--a plausible non-invasive depicter of glioblastoma proliferation and therapy response.
    Tsiouris S; Pirmettis I; Chatzipanagiotou T; Ptohis N; Papantoniou V
    J Neurooncol; 2007 Dec; 85(3):291-5. PubMed ID: 17554495
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The use of non-specific tracers in the follow up of differentiated thyroid cancer: results with Tc-99m tetrofosmin whole body scintigraphy.
    Lind P; Gallowitsch HJ
    Acta Med Austriaca; 1996; 23(1-2):69-75. PubMed ID: 8767519
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Reverse of the differential uptake intensity of Tc-99m MIBI and Tc-99m V-DMSA by multiple myeloma lesions in response to therapy.
    Athanasoulis T; Koutsikos J; Moulopoulos LA; Tsiouris S; Dimopoulos MA; Zerva C
    Clin Nucl Med; 2003 Aug; 28(8):631-5. PubMed ID: 12897645
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Is there a role for Tc-99m (V) DMSA scintigraphy in ischemic colitis?
    Stathaki MI; Koutroubakis IE; Koukouraki SI; Kouroumalis EA; Karkavitsas NS
    World J Gastroenterol; 2008 Sep; 14(35):5432-5. PubMed ID: 18803355
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Active inflammatory bowel disease: evaluation with 99mTc (V) DMSA scintigraphy.
    Koutroubakis IE; Koukouraki SI; Dimoulios PD; Velidaki AA; Karkavitsas NS; Kouroumalis EA
    Radiology; 2003 Oct; 229(1):70-4. PubMed ID: 12925713
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Does I-131-MIBG underestimate skeletal disease burden in neuroblastoma?
    Barai S; Bandopadhayaya GP; Malhotra A; Agarwal S; Kumar R; Dhanapathi H
    J Postgrad Med; 2004; 50(4):257-60; discussion 260-1. PubMed ID: 15623965
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Bone scintigraphy in the monitoring of treatment effect of bisphosphonates in bone metastatic breast cancer.
    Chavdarova L; Piperkova E; Tsonevska A; Timcheva K; Dimitrova M
    J BUON; 2006; 11(4):499-504. PubMed ID: 17309184
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pentavalent [99mTc]DMSA, [131I]MIBG, and [99mTc]MDP--an evaluation of three imaging techniques in patients with medullary carcinoma of the thyroid.
    Clarke SE; Lazarus CR; Wraight P; Sampson C; Maisey MN
    J Nucl Med; 1988 Jan; 29(1):33-8. PubMed ID: 2826723
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Evaluation of Tc-99m(V) DMSA for imaging inflammatory lesions: an experimental study.
    Ercan MT; Gülaldi NC; Unsal IS; Aydin M; Peksoy I; Hasçelik Z
    Ann Nucl Med; 1996 Nov; 10(4):419-23. PubMed ID: 9006727
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Nuclear medicine approaches in the monitoring of thyroid cancer patients.
    Sergieva S; Hadjieva T; Doldurova M; Stefanova S; Dudov A
    J BUON; 2006; 11(4):511-8. PubMed ID: 17309186
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Results of a five-year study of 99mTc DMSA renal scintigraphy in children and adolescents following acute pyelonephritis.
    Chroustová D; Palyzová D; Urbanová I; Kolská M
    Nucl Med Rev Cent East Eur; 2006; 9(1):46-50. PubMed ID: 16791804
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Synthesis of trans-1,2-cyclohexyldinitrilo tetramethylene phosphonic acid and its radiolabelling with 99mTc for the detection of skeletal metastases.
    Panwar P; Chuttani K; Mishra P; Sharma R; Mondal A; Kumar Mishra A
    Nucl Med Commun; 2006 Aug; 27(8):619-26. PubMed ID: 16829762
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Bone metastases demonstrated by pentavalent Tc-99m DMSA and Tc-99m HMDP.
    Hirano T; Otake H
    Clin Nucl Med; 1997 Sep; 22(9):640-1. PubMed ID: 9298304
    [No Abstract]   [Full Text] [Related]  

  • 57. Incidental DTPA and DMSA uptake during renal scanning in unknown bone metastases.
    Balci TA; Ciftci I; Karaoglu A
    Ann Nucl Med; 2006 Jun; 20(5):365-9. PubMed ID: 16878710
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Can 16-detector multislice CT exclude skeletal lesions during tumour staging? Implications for the cancer patient.
    Groves AM; Beadsmoore CJ; Cheow HK; Balan KK; Courtney HM; Kaptoge S; Win T; Harish S; Bearcroft PW; Dixon AK
    Eur Radiol; 2006 May; 16(5):1066-73. PubMed ID: 16402253
    [TBL] [Abstract][Full Text] [Related]  

  • 59. 99mTc bone scintigraphy superscans: a review.
    Buckley O; O'Keeffe S; Geoghegan T; Lyburn ID; Munk PL; Worsley D; Torreggiani WC
    Nucl Med Commun; 2007 Jul; 28(7):521-7. PubMed ID: 17538392
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Diagnostic value of pentavalent 99mTc-dimercaptosuccinicacid ([V]-DMSA) in head and neck tumors].
    An R; Bender H; Guhlke S; Biersack HJ
    J Tongji Med Univ; 2000; 20(4):303-7. PubMed ID: 12840918
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.